Investor Relations

Rigel's Mission

Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel, small molecule drugs that significantly improve the lives of patients with immune and hematological disorders, cancer and rare diseases.

Recent Event

Fourth Quarter and Year End 2020 Financial Results Conference Call

Latest Financial Results

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2020

mail icon

Sign Up For Email Alerts

Receive updates straight into your inbox

Sign up today

Investor Contact Information


Rigel Pharmaceuticals, Inc.
1180 Veterans Blvd
South San Francisco, CA 94080

Investor Relations

Rigel Pharmaceuticals, Inc.
David Burke
Director, Investor Relations & Communications

Transfer Agent

EQ Shareowner Services
T: 800-401-1957